Front Line COVID-19 Critical Care Alliance Statement on New Guidance on Ivermectin from the All India Institute of Medical Science
FOR IMMEDIATE RELEASE
April 29, 2021
WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19.
As COVID-19 cases in India continue to increase at an alarming rate this guidance is a welcome development for the country’s efforts to treat those in need. We encourage all medical authorities, hospitals, physicians and medical professionals in India to follow the latest guidance from AIIMS.
“We are grateful that the AIIMS has followed the science on ivermectin in creating the new guidelines,” said Pierre Kory, M.P.A., MD, president and chief medical officer of the FLCCC. “I expect that if implemented, we will begin to see a decline in cases as we have seen in other regions when there is widespread use of ivermectin.”
The new guidelines can be found on the AIIMS website here: https://covid.aiims.edu
About the Front Line COVID-19 Critical Care Alliance
The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol, introduced in March 2020, has saved thousands of patients who were critically ill with COVID-19. Now, the FLCCC’s new I-Mask+ Prophylaxis and Early At-Home Outpatient Treatment Protocol with Ivermectin has been released – and is a potential solution to the global pandemic.